Antigen presenting cells treated in vitro by macrophage colony-stimulating factor and autoantigen protect mice from autoimmunity
- 15 November 2007
- journal article
- research article
- Published by Elsevier in Journal of Neuroimmunology
- Vol. 192 (1-2) , 68-78
- https://doi.org/10.1016/j.jneuroim.2007.09.021
Abstract
No abstract availableKeywords
This publication has 52 references indexed in Scilit:
- Foxp3 in control of the regulatory T cell lineageNature Immunology, 2007
- IL-25 regulates Th17 function in autoimmune inflammationThe Journal of Experimental Medicine, 2007
- The lifestyle of naturally occurring CD4+CD25+Foxp3+ regulatory T cellsImmunological Reviews, 2006
- A crucial role for interleukin (IL)-1 in the induction of IL-17–producing T cells that mediate autoimmune encephalomyelitisThe Journal of Experimental Medicine, 2006
- Anti-IL-23 therapy inhibits multiple inflammatory pathways and ameliorates autoimmune encephalomyelitisJournal of Clinical Investigation, 2006
- Mechanisms of tolerance induced by TGFβ-treated APC: CD4 regulatory T cells prevent the induction of the immune response possibly through a mechanism involving TGFβEuropean Journal of Immunology, 2004
- Myelin Oligodendrocyte Glycoprotein–specific T Cell Receptor Transgenic Mice Develop Spontaneous Autoimmune Optic NeuritisThe Journal of Experimental Medicine, 2003
- CD1d on antigen-transporting APC and splenic marginal zone B cells promotes NKT cell-dependent toleranceEuropean Journal of Immunology, 2002
- Repetitive Injections of Dendritic Cells Matured with Tumor Necrosis Factor α Induce Antigen-specific Protection of Mice from AutoimmunityThe Journal of Experimental Medicine, 2001
- Effect of Human Macrophage Colony‐stimulating Factor on Granulopoiesis and Survival in Bone‐marrow‐transplanted MiceJapanese Journal of Cancer Research, 1990